IA
AMPH icon

IFP Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

IFP Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.41K Hold
70
– – ﹤0.01% 4385
2026
Q1 		$1.37K Sell
70
-900
-93% -$22K ﹤0.01% 4087
2025
Q4 		$26K Sell
970
-600
-38% -$15.5K ﹤0.01% 2590
2025
Q3 		$41.8K Sell
1,570
-465
-23% -$12K ﹤0.01% 2167
2025
Q2 		$51.9K Buy
2,035
+877
+76% +$21.8K ﹤0.01% 2026
2025
Q1 		$33.7K Buy
+1,158
New +$37K ﹤0.01% 2069
2024
Q4 		– Hold
0
– – – 4134
2023
Q1 		– Sell
-18
Closed -$3K – 3388
2022
Q4 		$3K Sell
18
-75
-81% -$2.18K ﹤0.01% 3971
2022
Q3 		$6K Sell
93
-86
-48% -$2.81K ﹤0.01% 3910
2022
Q2 		$7K Hold
179
– – ﹤0.01% 3577
2022
Q1 		$7K Buy
+179
New +$5.08K ﹤0.01% 3577
2019
Q1 		– Sell
-1,410
Closed -$28K – 2388
2018
Q4 		$28K Hold
1,410
– – ﹤0.01% 1934
2018
Q3 		$27K Buy
1,410
+100
+8% +$1.78K ﹤0.01% 2273
2018
Q2 		$20K Buy
1,310
+1,000
+323% +$17.5K ﹤0.01% 2458
2018
Q1 		$6K Hold
310
– – ﹤0.01% 3046
2017
Q4 		$6K Sell
310
-1,250
-80% -$23.3K ﹤0.01% 3092
2017
Q3 		$28K Buy
+1,560
New +$25.7K ﹤0.01% 2374

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

IFP Advisors's AMPH Position: Q2 2026 in Review

IFP Advisors held its Amphastar Pharmaceuticals (AMPH) position steady in Q2 2026 at 70 shares worth $1.41K. The position accounts for ﹤0.01% of the portfolio, ranked #4385.

IFP Advisors first reported a position in AMPH in Q3 2017 and has held it in 16 quarters since. The position peaked at $51.9K in Q2 2025. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • IFP Advisors held 70 shares of Amphastar Pharmaceuticals worth $1.41K as of Q2 2026.
  • IFP Advisors left its Amphastar Pharmaceuticals share count unchanged in Q2 2026.
  • Amphastar Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4385 holding.
  • IFP Advisors first reported a position in Amphastar Pharmaceuticals in Q3 2017 and has held it in 16 quarters since.
  • IFP Advisors's Amphastar Pharmaceuticals position peaked at $51.9K in Q2 2025.
  • 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.